Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 18.62----

What is the latest Price to Cash Earnings (PCE) ratio of EMCURE PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of EMCURE PHARMACEUTICALS is 18.62 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202518.62
Mar2024-
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of EMCURE PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 18.62
0
Mar2024 0
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,432.6 Cr -2.9% 6.5% 55.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,495.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹154,244.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,634.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,594.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹97,022.8 Cr -4.1% -11.5% -19% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.9%

6.5%

55.1%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses